Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe…

Sponsored by ModernaTX, Inc.Study detailsClinicalTrials.gov

150 US sites in AL, AZ, CA, CO +34

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.